Latest Stock Buy or Sell?

Today, Kevin O'Leary and Shannon Saccocia, CIO, Boston Private commented about whether CRM-N, WDAY-Q, TWTR-N, CVX-N, COIN-Q, ZTS-N, NSRGY-OTC, UN-N, SAP-N, OGIG-N are stocks to buy or sell.

SELL
He sold it, but missed the high price. Policy remains very oil negative. If the US mid-terms see a shift in person, he may return to this.
integrated oils
COMMENT
healthcare It's an okay place to be. Many companies have good balance sheets. Wait just in case there's another pandemic. He's weighted at 20% of his portfolio.
Unknown
BUY
There's big potential here, because it doesn't serve small businesses in America which equal 66% of digital ad spending which is going to Facebook and Google instead. This platform serves only large brands, but that's a smaller part of the market. Twitter has been miserable for investors and has seen a revolving door of CEOs. The fair price of the Elon Musk deal is $30/share. Musk will never find out the data he wants about bots because it would break privacy laws. It's at an impasse. Twitter should take the deal, but all this wrangling exposes what a mess there is in management there, and is scaring away large customers.
0
BUY
Sold Salesforce to buy Workday. She has liked CRM for many years. But Workday's work in HR and enterprise resource management. In the hybrid work environment, it could be important for employees to have a cloud platform to log into for recruiting and resource management. Workday has an excellent outlook for coming years.
0
SELL
Sold Salesforce to buy Workday. She has liked CRM for many years. But Workday's work in HR and enterprise resource management. In the hybrid work environment, it could be important for employees to have a cloud platform to log into for recruiting and resource management. Workday has an excellent outlook for coming years.
computer software / processing
BUY
It seems cheap, because they have 4-7 billion-dollar drugs in their pipeline. So, estimates will have to move up dramatically and the PE will be lower. Therefore, the stock doesn't look as expensive as it seems.
biotechnology / pharmaceutical
BUY
Actually, cloud stocks have held up relatively well compared to tech. In less than two months, shares have gone from $406 to $490, but remains over $200 from its peak. Business is good and NOW is actually profitable.
Technology